Clinical Trial Update: A Study of GNC-038 Tetra-specific Antibody Injection in Patients With Systemic Lupus Erythematosus [Phase 1]

View source ↗

Summary

An ongoing Phase 1 clinical trial evaluating GNC-038, a tetra-specific antibody, in patients with systemic lupus erythematosus, sponsored by Sichuan Baili Pharm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• GNC-038

Snippet

Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. | Conditions: Systemic Lupus Erythematosus | Phase 1 | Status: RECRUITING